Kenan Turnacioglu, Ph.D., is a biotech investor focused on healthcare and AI-driven biomedical solutions. See portfolio, sector focus and contact routes.
Kenan Turnacioglu, Ph.D., is a biotech investor focused on healthcare and AI-driven biomedical solutions, investing primarily in life sciences companies developing next-generation drugs, devices, diagnostics, and data tools. As a former General Partner at Catalio Capital Management, he supports companies across all stages from inception to IPO, with the firm targeting deals of $10 million to $50 million in its credit fund. His notable portfolio includes board roles at Massive Bio, Immunai, and PaigeAI, and angel investments in Network Bio, Sirona Medical, and Paige, reflecting a distinctive thesis on integrating artificial intelligence with patient care.
This profile is part of the StartupFundraising investor database: focus, portfolio history, disclosed location and contact routes, refreshed as new filings and rounds are ingested. Founders use it to check fit before reaching out and to find investors in New York.
Investors like Kenan Turnacioglu · Full investor directory · Investor access · Company funding database